Login

Karin Fischer, CEO, RLS Global 00:00:00

Share On Facebook Share On Twitter

Karin Fischer, CEO, RLS Global

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Assessing Modern Immigration: Challenges and Perspectives|Mark Krikorian
00:10:00
The Bargainer: Shelby Steele on Race and American Identity|Shelby Steele
00:10:00
In the first quarter, Korea Electric Power Corporation (KEPCO) reported a record loss of 7.8 trillion won, attributed to artificially low prices aimed at supporting consumers.
00:10:00
Exploring the Future of Brokerage with Brian Barnes: Insights from the CEO of M1 Finance | Brian Barnes - CEO and Founder of M1 Finance
00:10:00
The Impact of Emotions and Cognitive Biases on Investment Decisions
00:10:00
Kiliaro Group AB Q2 Report: Insights from CEO Elie Komo | Elie Komo, CEO, Kiliaro Group AB.
00:10:00
Dr. Martin Enderle, Founder & CEO of Scout24, presents at the NOAH 2012 Conference in San Francisco.
00:10:00
Upholding Innovation and Adaptability: CMIC's Enduring Creed | Kazuo Nakamura, CEO, CMIC Holdings Co Ltd.
00:10:00
Adapting Strategies in a New Macroeconomic Reality with Dominique Senequier | Dominique Senequier, President, Ardian.
00:10:00
TELUS International CEO Jeff Puritt discusses the company's position at the intersection of digital IT and customer experience with Nicole Petallides on #TheWatchList.
00:10:00
Phunware, Inc CEO Alan Knitowski confirms the formal closure of the acquisition of privately-held Lyte Technology, Inc in an interview with Proactive..|Mike Snavely is Chief Executive Officer & Director of Phunware
00:00:00
Tina Ardon, M.D. Family Physician, Mayo Clinic

© 2026 Nehu